The leaves are brown, the tem­per­a­ture is warm and Red Tree Ven­ture Cap­i­tal is dream­ing of Cal­i­for­nia — and some ...
Throughout the string of negative news coming out of Assembly Bio, CEO John McHutchison held on to the hope that his team of ...
It looks like Eli Lilly and Teva Pharmaceuticals are going to trial. A federal appeals court on Monday refused to invalidate ...
In a boost to its Asia Pacific regional headquarters in Singapore, Merck has opened a new secondary packaging facility and ...
A new spinout emerged from stealth Thursday morning, backed by big name VCs and Big Pharma veterans at the helm to try to ...
A growing gene therapy company is teaming up with one of the largest gene therapy manufacturers to get its drug into patients ...
Pfizer and BioNTech are collaborating with Marvel to celebrate “everyday” people getting Covid-19 vaccines in a custom comic ...
Zoom can only go so far. And I think at this stage, we’ve all tested the limits of staying in touch — virtually. So I’m ...
As Amylyx gets ready to debut its ALS drug in the US — amid scrutiny and criticism of the price it’s set — the biotech is ...
After being forced to delay two Phase IIa trials and blaming CMC issues on a Phase Ib miss, Eliem Therapeutics believes it’s ...
There are some odd-looking purple creatures lurking around the halls of AstraZenca lately. The “Phil” character cutouts are ...
What’s Biohaven without its CGRP portfolio? That’s what CEO Vlad Coric is tasked with deciding as he maps out the “New ...